The chemical class referred to as STOX2 Activators encompasses a diverse range of compounds that can engage with cellular signaling pathways and influence the expression or activity of the STOX2 protein. These activators are not a homogenous group but are instead a collection of molecules that share the functional capability of modulating the biological activity of STOX2. This modulation can occur through various mechanisms, including the alteration of transcriptional regulation, epigenetic modifications, and the initiation of signaling cascades that culminate in the enhanced expression or functional activation of STOX2.
These activators can operate by modifying the intracellular environment in a manner that promotes the transcription of the STOX2 gene. For example, some can affect the structure of chromatin, thereby increasing the accessibility of the STOX2 gene to the transcriptional machinery. Others can interact with upstream signaling pathways, which can lead to a cascade of intracellular events that ultimately upregulate STOX2 expression or increase its transcriptional activity. The precise mechanisms by which these activators function can vary widely, as they may target different aspects of cellular regulation. This includes influencing the activity of other transcription factors, altering the phosphorylation state of proteins involved in signaling pathways, or changing the levels of secondary messengers such as cAMP. The result of such interactions is an increased likelihood that STOX2 will be involved in its associated cellular functions, which can range from developmental processes to metabolic regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in gene expression during development; could possibly activate STOX2 expression as part of differentiation signaling. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase increasing cAMP levels, which could possibly activate transcription factor activity, affecting STOX2. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that regulates gene expression; could possibly activate STOX2 expression in certain cell types. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
A hormone that regulates metabolism; could possibly activate STOX2 activity as part of metabolic control in cells. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
PPARγ agonist that modulates metabolic processes; could possibly activate STOX2 activity through metabolic gene regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylases; could possibly activate transcription of STOX2 by affecting chromatin structure. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A histone deacetylase inhibitor; could possibly activate STOX2 expression by increasing chromatin accessibility. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3 leading to Wnt pathway activation; could possibly activate STOX2 expression through developmental pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which is part of the MAPK pathway; could possibly activate STOX2 activity through alterations in cell signaling. | ||||||